🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

17+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 17 of 17 recruiting trials for “Dengue fever”

Phase 3RecruitingNCT06891950 ↗

Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)

👨‍⚕️ Fernanda C Boulos, MD, PhD, Instituto Butantan📍 5 sites📅 Started Mar 2026View details ↗
NARecruitingNCT07412483 ↗

A Controlled Human Infection Model of Dengue

👨‍⚕️ Barnaby E Young, MB BChir, PhD, National Centre for Infectious Diseases (NCID)📍 1 site📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT06579755 ↗

A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

👨‍⚕️ Study Director, Takeda📍 7 sites📅 Started Jan 2026View details ↗
RecruitingNCT07409857 ↗

International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)

🏥 Mahidol University📍 1 site📅 Started Dec 2025View details ↗
Phase 2Enrolling by InvitationNCT07172100 ↗

To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia

🏥 Ziauddin Hospital📍 1 site📅 Started Oct 2025View details ↗
RecruitingNCT07007585 ↗

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

🏥 Jose Ivan Rodriguez de Molina Serrano📍 1 site📅 Started Aug 2025View details ↗
Phase 3RecruitingNCT06665035 ↗

A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers

👨‍⚕️ Study Director Study Director, Takeda📍 4 sites📅 Started Jun 2025View details ↗
RecruitingNCT07040202 ↗

Immune Responses to Dengue and Sepsis

👨‍⚕️ Tineke Cantaert, PhD, Institut Pasteur du Cambodge📍 3 sites📅 Started Jun 2025View details ↗
NARecruitingNCT06894901 ↗

Impact of IIT-SIT on Dengue Clusters

👨‍⚕️ Lee Ching Ng Group Director (Environmental Health Institute), PhD, Environmental Health Institute📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT06843226 ↗

A Study in Children and Adolescents on the Effectiveness of Takeda's Licensed Dengue Vaccine TDV Against Hospitalization Due to Dengue Disease

👨‍⚕️ Study Director, Takeda📍 3 sites📅 Started Mar 2025View details ↗
Phase 2, PHASE3RecruitingNCT06747130 ↗

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

👨‍⚕️ Worapong Nasomsong, MD, Phramongkutklao College of Medicine and Hospital📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06388785 ↗

A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia

👨‍⚕️ Study Director, Takeda📍 2 sites📅 Started Sep 2024View details ↗
RecruitingNCT06599970 ↗

Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility

👨‍⚕️ Veerle Vanlerberghe, Institute of Tropical Medicine📍 1 site📅 Started Jun 2024View details ↗
Phase 2RecruitingNCT04597437 ↗

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

👨‍⚕️ Aileen Chang, MD, George Washington University📍 2 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06006559 ↗

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

🏥 Novartis Pharmaceuticals📍 23 sites📅 Started Feb 2024View details ↗
RecruitingNCT04486638 ↗

Dengvaxia US Pregnancy Registry

👨‍⚕️ Clinical Sciences & Operations, Sanofi📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT04839757 ↗

Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean

👨‍⚕️ Andre CABIE, Martinique University Hospital Center📍 1 site📅 Started Jun 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →